Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.9116 per EA under NDC 67877014801. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
7.5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877014801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071457On Market Since
6/28/2012
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9116 per EA |
|---|---|
| All-time high | $5.1228 (Sep 10, 2014) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9430 |
| 52-week low | $0.7894 |
| Median price | $1.7382 |
| Average price | $2.2580 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.9116 per EA (NDC 67877014801), effective Jun 24, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has declined 79.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $5.1228 (Sep 10, 2014), with a median of $1.7382 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 7.5 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 67877014801) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification